SoftWave officially has been granted 4 new patents as of July 19, 200. They include e U.S. Patient No. 11,389,373 B2 for Acoustic shock wave therapeutic methods to prevent or treat opioid addiction, U.S. Patient No. 11,389,370 B2 for Treatments for blood sugar levels and muscle tissue optimization, U.S. Patient No. 11,389,371 B2 and U.S....Read More

Hypertrophic scars cause aesthetic concerns and negatively affect the quality of life. A gold standard treatment for hypertrophic scars has not been established due to various responses of modalities. Extracorporeal shock wave therapy (ESWT) is a noninvasive and affects scar remodeling by fibroblast regulation. This study investigated the effectiveness of ESWT for hypertrophic scars. Click...Read More

Exclusive agreement to supply Cynosure LLC, a global leader in medical aesthetics, with its patented extracorporeal shock wave devices for distribution in the United States and Canada primarily to medical doctors and their practices.Read More